Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

GlaxoSmithKline Consumer Nigeria

1971 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
GLAXOSMITH STOCK SYMBOL
$0.01 SHARE PRICE (As of Monday Closing)
Description

GlaxoSmithKline Consumer Nigeria PLC is healthcare company that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. The company has two reportable segments, Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines and nutritional healthcare; and Pharmaceuticals segment consisting of antibacterial, vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, Horlicks, and others. It also has focused on various research and development activities.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
NSA
Primary Office
  • GSK House, 1, Industrial Avenue
  • Ilupeju
  • Lagos, 100252
  • Nigeria
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore GlaxoSmithKline Consumer Nigeria’s full profile, request a free trial.

GlaxoSmithKline Consumer Nigeria Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.01 - $0.03 $16.2M $0.01 1.17M 1.2B

GlaxoSmithKline Consumer Nigeria Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 24,877 35,868 21,725 43,356
Revenue 54,449 50,776 47,812 54,655
EBITDA 4,403 3,192 793 3,386
Net Income 1,728 1,703 1,445 15,962
Total Assets 44,224 42,874 73,392 91,896
Total Debt 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer